Shanghai Zhicheng Biotechnology Co., Ltd. is a high-tech enterprise mainly engaged in the research and development, production, and sales of in vitro diagnostic equipment and reagents. Its products mainly include biochemical, immunological, and POCT products, including liver function series, kidney function series, blood lipid series, blood glucose metabolism series, etc.

"DENUO" is an exclusive brand of Shanghai Zhicheng Biochemical Products, founded in 2004, symbolizing a "moral commitment" to our customers, promising first-class product quality, first-class service quality, and corporate integrity. Since the establishment of the brand, DENUO reagents have received unanimous praise from medical and health institutions at all levels for their stable product quality and strict quality testing, shaping a good brand recognition in the industry.

At the same time, Shanghai Zhicheng actively expands its presence in the field of immune diagnosis. In 2018, it signed an agency agreement with Italy's Solling Diagnostic Medical Equipment (Shanghai) Co., Ltd., becoming LIAION's general agent in China and adding sales services for chemiluminescence immune diagnostic products.

In 2014, A-share listed company Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. merged and restructured, making Shanghai Zhicheng a wholly-owned subsidiary of Zhongyuan Xiehe. Together, they built a medical diagnosis platform that combines biochemistry, immunity, molecular and pathological diagnosis, and their comprehensive operating benefits are gradually fermenting.

Shanghai Zhicheng adheres to the principle of "being the best in the field of practice and based on integrity" to provide high-quality products and services to society. It actively participates in the construction of various regional testing centers and centralized procurement and distribution business in major hospitals across the country, gradually developing into a comprehensive service provider for medical laboratories.

Corporate Honors:

The company is one of the top ten companies in China and one of the top three in Shanghai in the sales model of in vitro biochemical diagnostic reagents.

One of the nine key taxpayers in Shanghai International Medical Park with over 10 million yuan.

The company has been recognized as a "Shanghai High tech Enterprise".

The company has been rated as a research and development institution in Pudong New Area, Shanghai.

The Nuclear Industry Association of the Shanghai Medical Bureau has rated it as a "market expansion+excellent enterprise".

The company has been recognized as a "Shanghai Science and Technology Cultivation Little Giant Enterprise".

The company has been recognized as a "Shanghai Integrity Creation Enterprise".

The total fatty acid product has been rated as a well-known and excellent product by the Shanghai Medical Bureau.

The company has passed the 1S013485 international quality certification system, laying the foundation for the international sales of its products.

COVID-19 neutralizing antibody test kit has obtained CE certification.